Drawn from the best-selling second edition of Essential Psychopharmacology, in this revised and updated new book Steve Stahl covers the many dimensions of psychosis (causes, pathophysiology, treatment and the role of dopamine). New material includes discussion of a promising new agent, aripiprazole, the first in a new class of dopamine stabilizers; the use of anticonvulsant agents; and the newest atypical antipsychotic ziprasidone. This book will be essential reading for all professionals treating psychosis, and students who need to know the mechanisms of drug actions. CME self-assessment tests are included.

This spin-off from Stephen M. Stahl's new, completely updated third edition of his much-acclaimed Prescriber's Guide covers drugs for psychosis and mood disorders.

This is a pragmatic, easy-to-use formulary for prescribing clinicians, covering the main antipsychotic and mood stabilization drugs.

Relying upon the best-selling third edition of Stahl's Essential Psychopharmacology, Dr Stephen M. Stahl has revised chapters covering antipsychotics and mood stabilizers for this edition. More than one-third longer than the previous edition it is essential reading for professionals treating psychosis and students learning the mechanisms of drug reactions. It includes advances in neurobiology and recent clinical developments to explain the concepts underlying drug treatment of psychiatric disorders. The fully revised text is complemented by many new illustrations and enhanced to reflect new knowledge and topics covered in the previous edition. Intended as a primer text covering all aspects of treatment for psychosis and related conditions, this concise volume can nevertheless be read cover to cover by experts and novices alike. Accreditation and Credit Designation Statements The Neuroscience Education Institute is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The Neuroscience Education Institute designates this educational activity for a maximum of 90.0 AMA PRA Category 1 Credits(tm). Physicians should only claim credit commensurate with the extent of their participation in the activity. Sponsorship Information Sponsored by Neuroscience Education Institute Support This activity is supported solely by the sponsor. Neither the Neuroscience Education Institute nor Stephen M. Stahl, MD, PhD has received any funds or grants in support of this educational activity.

The updated Second Edition includes nearly double the number of medications, pharmacogenetics, updated warnings, indications and tips.